ADVERSE EFFECTS OF ANDROGEN DEPRIVATION THERAPY ON PATIENTS WITH PROSTATE CANCER AND ITS EFFECT ON OVERALL SURVIVAL-Reference-Cited by-同舟云学术

ADVERSE EFFECTS OF ANDROGEN DEPRIVATION THERAPY ON PATIENTS WITH PROSTATE CANCER AND ITS EFFECT ON OVERALL SURVIVAL

Published:2021-04-20 Issue:2 Volume:112 Page:81-88
ISSN:0021-5287
Container-title:The Japanese Journal of Urology
language:en
Short-container-title:Jpn. j. urol

Author:

Shimabukuro Tomoyuki¹,Ohmi Chietaka¹,Nagamitsu Ryoko¹,Shiraishi Koji²,Matsuyama Hideyasu²

Affiliation:

1. Department of Urology, Ube-kosan Central Hospital Corp

2. Department of Urology, Graduate School of Medicine, Yamaguchi University

Publisher

Japanese Urological Association

Subject

Urology

Link

https://www.jstage.jst.go.jp/article/jpnjurol/112/2/112_81/_pdf

Reference34 articles.

1. 1) Huggins C and Hodges CV: Studies on prostate cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res, 1, 293-297, 1941.

2. 2) Akaza H, Hinotsu S, Usami M, Arai Y, Kanetake H, Naito S and Hirao Y: Combined androgen blockade with bicalutamide for advanced prostate cancer. Long-term follow-up of a phase 3, double-blind, randomized study for survival. Cancer, 115(15), 3437-3445, 2009.

3. 3) Onozawa M, Akaza H, Hinotsu S, Oya M, Ogawa O, Kitamura T, Suzuki K, Naito S, Namiki M, Nishimura K, Hirao Y and Tsukamoto T: Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching. Cancer Med., 7(10), 4893-4902, 2018.

4. 4) Higano CS: Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology, 61(Suppl 2A), 32-38, 2003.

5. 5) Sharifi N, Gulley JL and Dahut WL: Androgen deprivation therapy for prostate cancer. JAMA, 294, 238-244, 2005.